...
首页> 外文期刊>Cell >CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset
【24h】

CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset

机译:CAG重复不是polyglutamine长度决定了亨廷顿疾病发病的时序

获取原文
获取原文并翻译 | 示例
           

摘要

Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin's polyglutamine segment, dictates the rate at which Huntington's disease (HD) develops. The timing of onset shows no significant association with HTT cis-eQTLs but is influenced, sometimes in a sex-specific manner, by polymorphic variation at multiple DNA maintenance genes, suggesting that the special onset-determining property of the uninterrupted CAG repeat is a propensity for length instability that leads to its somatic expansion. Additional naturally occurring genetic modifier loci, defined by GWAS, may influence HD pathogenesis through other mechanisms. These findings have profound implications for the pathogenesis of HD and other repeat diseases and question the fundamental premise that polyglutamine length determines the rate of pathogenesis in the "polyglutamine disorders.''
机译:变量,谷氨酰胺编码,CAA中断表明,不间断的HTT CAG重复序列的性质,不同于亨廷顿的聚谷氨酰胺部分的长度,决定了亨廷顿疾病(HD)发展的速率。 发病的时序显示出与HTT CIS-EQTLS的显着关联,但有时以多种DNA维持基因的多态变化影响,有时是性特异性的方式,这表明不间断的CAG重复的特殊发作测定性能是一种倾向 对于长度不稳定,导致其体细胞扩张。 由GWA定义的另外的天然存在的遗传改性基因座,可以通过其他机制影响HD发病机制。 这些发现对HD和其他重复疾病的发病机制具有深远的影响,并质疑聚谷氨酰胺长度决定“聚谷氨酰胺紊乱”中发病机制率的基本前提。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号